| Literature DB >> 30708938 |
Kamel A Saleh1, Tahani H Albinhassan2, Serage Eldin I Elbehairi3, Mohammed A Alshehry4, Mohammad Y Alfaifi5, Adel M Al-Ghazzawi6, Mohamed A Al-Kahtani7, Abdullah D A Alasmari8.
Abstract
Natural products, especially secondary metabolites produced by plants under stressed conditions, are shown to have different pharmacological impacts from one to another. Aeluropus lagopoides is one of the common halophyte plants that survive under stressed conditions, and has been used for healing wounds and as a painkiller. The bioactivity and the chemical composition of this plant have been poorly investigated. Consequently, the chemical components of A. lagopoides leaves were extracted using hexane (nonpolar), ethyl acetate (semi-polar), and n-butanol (polar) to extract the most extensive variety of metabolites. The cytotoxicity and anticancer impact of extracted secondary metabolites were evaluated against breast (MCF-7), colon (HCT-116), and liver (HepG2) cancer cell lines using a SulphoRhodamine-B (SRB) test. Their mechanisms of action were verified by observing the appearance of apoptotic bodies using the fluorescent microscope, while their antiproliferative impacts were evaluated using a flow cytometer. Results revealed that secondary metabolites extracted using hexane and ethyl acetate had the highest cytotoxicity and thus the greatest anticancer activity effect on HepG2 with IC50 (24.29 ± 0.85 and 11.22 ± 0.679 µg/mL, respectively). On the other hand, flow cytometer results showed that secondary metabolites could inhibit the cell cycle in the G0/G1 phase. To ascertain the chemical composition⁻function relationship, the extracts were analyzed using LC-MS/MS. Accordingly, A. lagopoides hexane and ethyl acetate extracts may contain agents with anticancer potential.Entities:
Keywords: Aeluropus lagopoides; HCT-116; HepG2; LC-MS/MS; MCF-7; apoptosis
Mesh:
Substances:
Year: 2019 PMID: 30708938 PMCID: PMC6384719 DOI: 10.3390/molecules24030507
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
IC50 (µg/mL) of different extracts of A. lagopoides in different solid tumor cell lines.
| Extract | MCF-7 | HCT-116 | HepG2 |
|---|---|---|---|
| Hexane | 32.7 ± 0.58 | 27.79 ± 0.71 | 24.29 ± 0.85 |
| Ethyl acetate | 28.03 ± 0.98 | 34.6 ± 0.82 | 11.22 ± 0.679 |
| <100 | <100 | <100 | |
| Doxorubicin | 0.6 ± 0.022 | 0.45 ± 0.0516 | 0.42 ± 0.103 |
Figure 1Dose-response curve of different extracts of A. lagopoides in solid tumor cell lines MCF-7, HCT-116, and HepG2. Cells were exposed to the extracts for 72 h. Cell viability was determined using SRB-U SulphoRhodamine-B assay and data are expressed as mean ± S.D. (n = 3).
Figure 2Morphological changes of HCT-116, MCF-7, and HepG2 cells induced by the IC50 concentration of hexane and ethyl acetate extracts of A. lagopoides for 48 h, stained with AO/EB. The images were taken using fluorescence microscopy at 20×. MB: membrane blebbing; CC: chromatin condensation; EA: early apoptosis; LA: late apoptosis; AB: an apoptotic body; N: necrosis. Scale bar: 2 µm.
Effects of hexane and ethyl acetate extracts of A. lagopoides on the cell cycle distribution of three tumor cell lines over 24 h, compared with control cells.
| Tumor Cell Line | Compound | Cell Cycle Phase | ||
|---|---|---|---|---|
| G0/G1 | S | G2/M | ||
| HCT-116 | Control | 44.8 ± 0.85 | 51.79 ± 0.59 | 3.41 ± 0.29 |
| Hexane extract | 69.59 ± 0.38 | 26.28 ± 0.52 | 4.12 ± 0.89 | |
| Ethyl acetate extract | 67.57 ± 0.58 | 26.6 ± 0.58 | 5.8 ± 0.89 | |
| MCF-7 | Control | 45.4 ± 0.97 | 46.2 ± 0.81 | 8.34 ± 0.93 |
| Hexane extract | 61.8 ± 0.9 | 25.91 ± 0.59 | 12.21 ± 0.31 | |
| Ethyl acetate extract | 70.82 ± 0.49 | 25.3 ± 0.8 | 3.8 ± 0.75 | |
| HepG2 | Control | 50.48 ± 0.62 | 43.3 ± 0.71 | 6.21 ± 0.36 |
| Hexane | 72.79 ± 0.6 | 26.91 ± 0.9 | 0.3 ± 0.51 | |
| Ethyl acetate | 78.3 ± 0.40 | 21.5 ± 0.5 | 0.19 ± 0.33 | |
Figure 3Effect of hexane and ethyl acetate fractions of A. lagopoides aqueous ethanol crude extract on the cell cycle distribution of different cancer cells. Cells were exposed to hexane extract (B) and ethyl acetate extract (C) for 48 h and compared with cell control (A). Cell cycle distribution was determined using DNA cytometry analysis, and different cell phases plotted. (D) Percent of total events (n = 3).
LC-MS/MS analysis of hexane crude extracts of A. lagopoides leaves.
| No | Rt | Compound Name | Compound Formula | [M + H]+ Found for ms | [M + H]+ Found for ms/ms | [M + H]+ Calculated | Mass Error | Uncertainty in | Ref. |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 7.42 | Paracoumaryl alcohol | C9H10O2 | 151.0755 | 133.0564, 123.0438, 77.0397, 45.0342 | 151.0765 | −6.6192 | ±0.0010 | |
| 2 | 5.41 | Dihydrojasmone | C11H18O | 167.1432 | 79.0542, 59.0487, 31.01182 | 167.1441 | −5.3846 | ±0.0009 | |
| 3 | 6.89 | Iridodial | C10H16O2 | 169.1223 | 95.0659, 67.0547, 57.0705 | 169.1234 | −6.5041 | ±0.0011 | |
| 4 | 5.50 | Jasmolone | C11H16O2 | 181.1222 | 163.0389, 149.0236, 84.9599 | 181.1234 | −6.6253 | ±0.0012 | |
| 5 | 6.81 | Callicarpenal | C16H26O | 235.2058 | 217.1991, 91.0538, 81.0693, 57.0696 | 235.2067 | −3.8264 | ±0.0009 | |
| 6 | 6.53 | Neoflavan | C15H12O2 | 225.091 | 105.0336, 77.0385 | 225.0921 | −4.8869 | ±0.0011 | |
| 7 | 6.39 | Bakuchiol (terpenophenol) | C18H24O | 257.1898 | 121.1003, 95.0666, 43.0175 | 257.1910 | −4.6658 | ±0.0.0012 | [ |
| 8 | 8.87 | Desmosterol | C27H44O | 385.3469 | 109.0649, 97.0648, 81.0704 | 385.3476 | −1.8165 | ±0.0007 | [ |
| 9 | 8.20 | Stigmasta-1,3,5-triene | C29H46 | 395.3677 | 150.1160, 145.1011, 81.0699 | 395.3683 | −1.5176 | ±0.0006 | |
| 10 | 8.27 | Stigmastan-3,5-diene | C29H48 | 397.3830 | 147.1180, 95.0672, 81.0707 | 397.3840 | −2.5165 | ±0.0010 | |
| 11 | 9.01 | Brassicasterol | C28H46O | 399.3622 | 109.0648, 97.0645, 81.0698 | 399.3632 | −2.5040 | ±0.0010 | [ |
| 12 | 8.11 | δ-tocopherol | C27H46O2 | 403.3580 | 137.0604, 57.0700 | 403.3582 | −0.4958 | ±0.0002 | [ |
LC-MS/MS analysis ethyl acetate crude extracts of A. lagopoides leaves.
| No | Rt | Compound Name | Compound Formula | [M + H]+ Found for ms | [M + H]+ Found for ms/ms | [M + H]+ Calculated | Mass Error | Uncertainty in | Ref. |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1.79 | 7-Deoxyloganetic acid | C10H14O4 | 199.0967 | 149.0211, 98.9830, 69.0699 | 199.0976 | −4.52040 | ±0.0009 | |
| 2 | 7.26 | Rodundone | C15H22O | 219.1743 | 203.1441, 133.1017, 119.0553 | 219.1754 | −5.0188 | ±0.0011 | |
| 3 | 5.04 | Loganetin | C11H16O5 | 229.1070 | 99.0080, 95.0859, 67.0538 | 229.1081 | −4.8012 | ±0.0011 | |
| 4 | 5.76 | Pratensein | C16H12O6 | 301.0707 | 286.0478, 258.0526 | 301.0718 | −3.6536 | ±0.0011 | [ |
| 5 | 5.91 | psi-Tectorigenin | C16H12O6 | 301.0707 | 286.0478, 258.0526 | 301.0718 | −3.6536 | ±0.0011 | |
| 6 | 6.7 | Cirsiliol | C17H14O7 | 331.0813 | 109.1011, 95.0655, 81.0697 | 331.0823 | −3.0204 | ±0.0010 | [ |
LC gradient parameters.
| Time (min) | Flow Rate (mL/min) | A Conc. | B Conc. |
|---|---|---|---|
| 0.00 | 0.7 | 90.0 | 10.0 |
| 7.00 | 0.7 | 2.00 | 98.0 |
| 8.50 | 0.7 | 2.00 | 98.0 |
| 8.60 | 0.7 | 90.0 | 10.0 |
| 9.50 | Stop | ||